|
|
Article: Biotica Raises $5 Million in Venture Financing.
- Article from:
- PR Newswire
- Article date:
- January 6, 2003
CopyrightCOPYRIGHT 2003 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
CAMBRIDGE, England -- CAMBRIDGE, England, Jan. 6 /PRNewswire/ -- Biotica Technology Limited announced today the completion of a $5 million Series A round of financing, led by Biotechnology Value Fund (San Francisco, CA) with co-investor Nordic Biotech (Copenhagen). Marc Schneidman and Florian Schonharting will join the Board of Biotica, representing BVF and Nordic Biotech respectively.
Biotica's proprietary technology, spun out from the University of Cambridge, is based on the pioneering research of Professors Peter Leadlay and Jim Staunton in the area of polyketide biosynthesis. Biotica is focused on applying its drug discovery technology to engineer novel ...